| VL coverage |
Percentage of patients receiving ART at the site who had received VL testing during the first 12 months of ART -
-
Numerator: number of patients who had at least one VL screening during 3 to 12 months of ART
-
-
Denominator: number of patients retained on ART at 12 months after initiation at the site who by national policy should have had a VL performed during 3 to 12 months of ART
|
Desirable: ≥90% |
| Fair: 80 to 89% |
| Poor: <80% |
| VL suppression |
Percentage of patients receiving ART at the site whose VL was <1,000 copies/ml during the first 12 months -
-
Numerator: number of patients whose VL (the latest VL tested during 3 to 12 months of ART) was <1,000 copies/ml
-
-
Denominator: number of patients retained on ART at 12 months after initiation who had at least one time VL screening during 3 to 12 months of ART
|
Desirable: ≥90% |
| Fair: 80 to 89% |
| Poor: <80% |
| Retention in care |
Percentage of patients known to be alive and on treatment 12 months after initiation of ART -
-
Numerator: number of patients who are still alive and on ART 12 months after initiation
-
-
Denominator: number of patients who were expected to achieve 12-month outcomes within the reporting year, including those recorded as dead, stopped therapy, or lost to follow-up during 12 months of ART
|
Desirable: >85% |
| Fair: 75 to 85% |
| Poor: <75% |
| Lost to follow-up |
Percentage of patients lost to follow-up at 12 months of ART -
-
Numerator: number of patients who did not return to the clinic >90 days after the last missed appointment or drug pick-up date during 12 months of ART
-
-
Denominator: number of patients who were expected to achieve 12-month outcomes within the reporting year, excluding those who were recorded as dead or transferred out during 12 months of ART
|
Desirable: <5% |
| Fair: 5 to 10% |
| Poor: >10% |
| Dispensing practices |
Percentage of patients prescribed mono or dual ARV therapy -
-
Numerator: number of patients receiving ART at the end of the reporting year and prescribed a regimen consisting of one or two ARVs at their last clinic visit
-
-
Denominator: number of patients receiving ART at the end of the reporting year
|
Desirable: 0% |
| Poor: >0% |
| On-time pill pick-up |
Percentage of patients who picked up ART no more than two days late at the first pick-up after baseline pick-up -
-
Numerator: number of patients prescribed ART during a baseline month who returned for their next pill on time (within 2 days of their baseline month prescription running out if taken according to schedule)
-
-
Denominator: number of patients prescribed ART during the baseline month of the reporting year
|
Desirable: >90% |
| Fair: 80 to 90% |
| Poor: <80% |
| Pharmacy stock-outs |
Percentage of months in a reporting year in which there were no ARV drug stock-out -
-
Numerator: number of months in the reporting year in which there were no stock-out day of any ARV drug routinely used at the site
-
-
Denominator: 12 months
|
Desirable: 100% |
| Poor: <100% |
